Myeloproliferative neoplasms in pregnancy: ways to go

Noa Lavi¹, Benjamin Brenner^{2

3}

Affiliations

¹ Department of Haematology & Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel.
² Department of Haematology & Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel. b_brenner@rambam.health.gov.il.
³ Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel. b_brenner@rambam.health.gov.il.

Editorial

Noa Lavi et al. Br J Haematol. 2016 Oct.

. 2016 Oct;175(1):7-9.

doi: 10.1111/bjh.14290. Epub 2016 Sep 7.

Noa Lavi¹, Benjamin Brenner^{2

3}

¹ Department of Haematology & Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel.
² Department of Haematology & Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel. b_brenner@rambam.health.gov.il.
³ Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel. b_brenner@rambam.health.gov.il.

No abstract available

Keywords: myeloproliferative neoplasms; pregnancy.

Comment on

Pregnancy outcomes in myeloproliferative neoplasms: UK prospective cohort study.
Alimam S, Bewley S, Chappell LC, Knight M, Seed P, Gray G, Harrison C, Robinson S. Alimam S, et al. Br J Haematol. 2016 Oct;175(1):31-6. doi: 10.1111/bjh.14289. Epub 2016 Sep 9. Br J Haematol. 2016. PMID: 27612319